repository
대장암에서 AKT/mTOR 경로를 통한 옥살리플라틴 내성 발현에 관한 연구
- Alternative Title
- Sun Young Park
- Author(s)
- 박선영
- Alternative Author(s)
- Sun Young Park
- Advisor
- 김소희
- Department
- 일반대학원 약학과
- Publisher
- The Graduate School, Ajou University
- Publication Year
- 2020-02
- Language
- eng
- Keyword
- AKT-mTOR; LC3B; chemoresistance; colon cancer; oxaliplatin
- Alternative Abstract
- Oxaliplatin is a third-generation platinum analog that can interfere with DNA replication and transcription by DNA damage. Continuous exposure of oxaliplatin resulted in resistance to oxaliplatin but no mechanisms of oxaliplatin-resistance were reported. In this study, oxaliplatin resistant cells were established using HCT116, HT29, SW480 and SW620 colon cancer cells by gradually increasing drug concentration up to a maximum of 2 µM at least for 3 month. The 50% inhibitory concentrations of cell growth (IC50) of oxaliplatin were 5.34, 9.88, 10.1 and 9.49-fold higher in oxaliplatin resistant HCT116, HT29, SW480, and SW620 cells, respectively, compared to their respective parental cells. One mechanism is that the expression of AKT and mTOR proteins were overexpressed in the oxaliplatin-resistant colon cancer cells. In addition, the expression of LC3B, an autophagy marker, decreased along with increasing AKT/mTOR signals, which caused the increase in glucose metabolism to produce energy for cell survival in oxaliplatin-resistant cancer cells. Taken together, oxaliplatin-resistance might be mediated through the activation of AKT/mTOR pathway in colon cancer cells, and AKT/mTOR might be a potential targets for oxaliplatin-resistance in human colon cancers.
- Fulltext
- Appears in Collections:
- Graduate School of Ajou University > Department of Pharmacy > 3. Theses(Master)
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
-
- License
- STATISTICS
- Total Visit :3,544,039
- Total Download :1,795
- Today View :6,404
